47 Rue Adrienne Bolland
Ncardia innovative hiPSC-based products and services for drug discovery & cell therapy
Ncardia was formed in August 2017 following an acquisition by Pluriomics. Pluriomics was founded in 2011 by Stefan Braam and Herman Spolders, together with the scientific founders Prof. Dr. Mummery and Prof. Dr. Passier.
At the moment Ncardia is a leading contract research organisation in human cardiovascular and neural stem cell drug discovery, encompassing disease modeling, iPSC manufacturing and iPSC-based screening. The dedicated people, our industry knowledge and stem cell expertise enables us to develop and generate more innovative stem cell based services to serve our customers.
The Board of Directors of Ncardia consists of:
Ncardia is a privately held Belgium-based company with subsidiaries in the Netherlands and the USA. The investor base of the company includes both public and private funds including Vesalius Biocapital, SFPI-FPIM, SambrInvest, InnovationQuarter, S.R.I.W, Sino-German beta Holding Co. Ltd and founders.
Ncardia has attracted a leadership team of international experts in the areas of commercialization, pharma services, finance, stem cell R&D and manufacturing.
The management team consists of: